Exagen Inc. (XGN) Free cash flow 2018–2025
Exagen Inc. (XGN) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$14.3MFY2025 · since FY2018: -$9.5M → -$14.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$14.3M | -3.4% |
| FY2024 | -$13.8M | +9.8% |
| FY2023 | -$15.3M | +58.1% |
| FY2022 | -$36.5M | -61.1% |
| FY2021 | -$22.6M | -55.7% |
| FY2020 | -$14.5M | -43.8% |
| FY2019 | -$10.1M | -6.5% |
| FY2018 | -$9.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice